Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.
Open | $1.38 |
Close | $1.70 |
Volume / Avg. | 48.20M / 5.06M |
Day Range | 1.35 - 2.41 |
52 Wk Range | 0.46 - 10.00 |
Market Cap | $4.61M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 1.5% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Virpax Pharmaceuticals (NASDAQ:VRPX) through any online brokerage.
Other companies in Virpax Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), Biofrontera (NASDAQ:BFRI) and cbdMD (AMEX:YCBD).
There is no analysis for Virpax Pharmaceuticals.
Virpax Pharmaceuticals has a consensus price target of $3.00.
The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $1.68 last updated Today at July 19, 2024 at 5:02 PM EDT.
There are no upcoming dividends for Virpax Pharmaceuticals.
Virpax Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Virpax Pharmaceuticals.
Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.